Publications by authors named "K Katahira"

Background: Risk preference changes nonlinearly across development. Although extensive developmental research on the neurotypical (NTP) population has shown that risk preference is highest during adolescence, developmental changes in risk preference in autistic (AUT) people, who tend to prefer predictable behaviors, have not been investigated. Here, we aimed to investigate these changes and underlying computational mechanisms.

View Article and Find Full Text PDF

Background: The decision-making process has been investigated separately in the context of externally guided decision-making (EDM, e.g., a gambling task) and internally guided decision-making (IDM, e.

View Article and Find Full Text PDF

Background: Profiling or clustering individuals based on personality and other characteristics is a common statistical approach used in marketing, medicine, and social sciences. This approach improves data simplicity, supports the implementation of a data-driven decision-making process, and guides intervention strategies, such as personalized care. However, the clustering process involves loss of information owing to the discretization of continuous variables.

View Article and Find Full Text PDF

Background: Smartphone apps and wearable activity trackers are increasingly recognized for their potential to promote physical activity (PA). While studies suggest that the use of commercial mobile health tools is associated with higher PA levels, most existing evidence is cross-sectional, leaving a gap in longitudinal data.

Objective: This study aims to identify app-use patterns that are prospectively associated with increases in and maintenance of PA.

View Article and Find Full Text PDF
Article Synopsis
  • The research focuses on creating drug delivery systems (DDSs) to transport medications effectively to the brain, targeting central nervous system diseases like schizophrenia.* -
  • It describes the development of a new strategy using two peptides, KS-487 for targeting the brain and KS-133 as the actual drug, which were combined to enhance drug delivery across the blood-brain barrier.* -
  • The study shows that administering nanoparticles containing these peptides leads to improved cognitive functions in mouse models of schizophrenia, marking a significant advancement in potential therapies for this condition.*
View Article and Find Full Text PDF